Literature DB >> 24105395

Gut microbiota affects sensitivity to acute DSS-induced colitis independently of host genotype.

Brigitta M Brinkman1, Anne Becker, Rene B Ayiseh, Falk Hildebrand, Jeroen Raes, Geert Huys, Peter Vandenabeele.   

Abstract

Caspase-deficient mice and wild-type (WT) mice show significant differences in their gut microbiota composition. These differences coincide with the observation that caspase-3-deficient mice carrying a natural caspase-11 mutation (Casp3/11(-/-)) are less sensitive to acute dextran sodium sulfate-induced colitis than WT mice. For these reasons, we investigated the role of the microbiota in the development of colitis by cohousing WT and Casp3/11(-/-) mice. Microbial community fingerprinting by denaturing gradient gel electrophoresis analysis revealed that the similarities in gut microbial composition of WT and Casp3/11(-/-) mice increased after cohousing. In the acute dextran sodium sulfate-induced colitis model, Casp3/11(-/-) mice that were cohoused with WT mice showed increased weight loss and disease activity scores and increased neutrophil infiltration and inflammatory cytokine levels in their colon tissue compared with Casp3/11(-/-) mice that were not cohoused with WT mice. Also, we demonstrate that only the microbiota of the Casp3/11(-/-) mice cohoused with WT mice showed an important increase in Prevotella species. In conclusion, our cohousing experiments revealed that the colitogenic activity of the WT microbiota is transferable to Casp3/11(-/-) mice and that Prevotella species are likely to be involved. By contrast, the relative protection of Casp3/11(-/-) mice against dextran sodium sulfate damage is not transferred to WT mice after cohousing. These results underscore the need for in-depth studies of the bilateral interaction of host genes and microbiota to gain insight into the mechanisms of disease pathogenesis. Our findings also have important implications for the experimental design of disease studies in genetically modified mice and conclusions drawn from them.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105395     DOI: 10.1097/MIB.0b013e3182a8759a

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  36 in total

1.  Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation.

Authors:  Deepika Sharma; Ankit Malik; Michael D Steury; Peter C Lucas; Narayanan Parameswaran
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

2.  Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice.

Authors:  Bill Vestergaard; Łukasz Krych; Leif R Lund; Bettina P Jørgensen; Lars Hansen; Henrik E Jensen; Dennis S Nielsen; Axel K Hansen
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death.

Authors:  Debby Laukens; Lindsey Devisscher; Lien Van den Bossche; Pieter Hindryckx; Roosmarijn E Vandenbroucke; Yves-Paul Vandewynckel; Claude Cuvelier; Brigitta M Brinkman; Claude Libert; Peter Vandenabeele; Martine De Vos
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

4.  Environmental Factors Modify the Severity of Acute DSS Colitis in Caspase-11-Deficient Mice.

Authors:  Ting-Jia Fan; Sandrine Y Tchaptchet; Diana Arsene; Yoshiyuki Mishima; Bo Liu; R Balfour Sartor; Ian M Carroll; Edward A Miao; Anthony A Fodor; Jonathan J Hansen
Journal:  Inflamm Bowel Dis       Date:  2018-10-12       Impact factor: 5.325

5.  Lack of Effect of Murine Astrovirus Infection on Dextran Sulfate-induced Colitis in NLRP3-deficient Mice.

Authors:  Susan R Compton; Carmen J Booth; James D Macy
Journal:  Comp Med       Date:  2017-10-01       Impact factor: 0.982

Review 6.  Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.

Authors:  Alexa R Weingarden; Byron P Vaughn
Journal:  Gut Microbes       Date:  2017-02-10

7.  Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.

Authors:  Lien Van den Bossche; Pieter Hindryckx; Lindsey Devisscher; Sarah Devriese; Sophie Van Welden; Tom Holvoet; Ramiro Vilchez-Vargas; Marius Vital; Dietmar H Pieper; Julie Vanden Bussche; Lynn Vanhaecke; Tom Van de Wiele; Martine De Vos; Debby Laukens
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

Review 8.  Impact of the gut microbiota on rodent models of human disease.

Authors:  Axel Kornerup Hansen; Camilla Hartmann Friis Hansen; Lukasz Krych; Dennis Sandris Nielsen
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

9.  Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.

Authors:  Chang Sup Lee; Kristen K Penberthy; Karen M Wheeler; Ignacio J Juncadella; Peter Vandenabeele; Jeffrey J Lysiak; Kodi S Ravichandran
Journal:  Immunity       Date:  2016-03-29       Impact factor: 31.745

10.  Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage.

Authors:  Yehudit Shabat; Yoav Lichtenstein; Yaron Ilan
Journal:  Inflammation       Date:  2020-09-25       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.